Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Return on Capital Employed: 2011-2021

Historic Return on Capital Employed for Neurocrine Biosciences (NBIX) over the last 10 years, with Sep 2021 value amounting to 0.05%.

  • Neurocrine Biosciences' Return on Capital Employed fell 10.00% to 0.05% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.05%, marking a year-over-year decrease of 10.00%. This contributed to the annual value of 0.12% for FY2019, which is 8.00% up from last year.
  • Per Neurocrine Biosciences' latest filing, its Return on Capital Employed stood at 0.05% for Q3 2021, which was down 28.43% from 0.07% recorded in Q2 2021.
  • Over the past 5 years, Neurocrine Biosciences' Return on Capital Employed peaked at 0.32% during Q2 2020, and registered a low of -0.68% during Q1 2017.
  • Moreover, its 3-year median value for Return on Capital Employed was 0.08% (2021), whereas its average is 0.10%.
  • As far as peak fluctuations go, Neurocrine Biosciences' Return on Capital Employed plummeted by 43bps in 2017, and later spiked by 56bps in 2018.
  • Neurocrine Biosciences' Return on Capital Employed (Quarterly) stood at -0.18% in 2017, then grew by 22bps to 0.04% in 2018, then increased by 6bps to 0.11% in 2019, then grew by 11bps to 0.16% in 2020, then declined by 10bps to 0.05% in 2021.
  • Its Return on Capital Employed was 0.05% in Q3 2021, compared to 0.07% in Q2 2021 and 0.08% in Q1 2021.